Cargando…

Rosiglitazone ameliorates tissue plasminogen activator‐induced brain hemorrhage after stroke

OBJECTIVE: Delayed thrombolytic therapy with recombinant tissue plasminogen activator (tPA) may exacerbate blood‐brain barrier (BBB) breakdown after ischemic stroke and lead to catastrophic hemorrhagic transformation (HT). Rosiglitazone(RSG), a widely used antidiabetic drug that activates peroxisome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yan, Zhu, Zi‐Yu, Lu, Bing‐Wei, Huang, Ting‐Ting, Zhang, Yue‐Man, Zhou, Na‐Ying, Xuan, Wei, Chen, Zeng‐Ai, Wen, Da‐Xiang, Yu, Wei‐Feng, Li, Pei‐Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887660/ https://www.ncbi.nlm.nih.gov/pubmed/31756041 http://dx.doi.org/10.1111/cns.13260

Ejemplares similares

Rosiglitazone ameliorates palmitic acid-induced cytotoxicity in TM4 Sertoli cells
por: Ge, Xie, et al.
Publicado: (2018)

The peripheral immune response after stroke—A double edge sword for blood‐brain barrier integrity
por: Li, Yan, et al.
Publicado: (2018)

Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis
por: Li, Bing-Hu, et al.
Publicado: (2022)

Effect of rosiglitazone on amyloid precursor protein processing and Aβ clearance in streptozotocin-induced rat model of Alzheimer’s disease
por: Wang, Li, et al.
Publicado: (2017)

Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner
por: Wei, Jun-Yu, et al.
Publicado: (2022)

The Protective Role of Immunomodulators on Tissue-Type Plasminogen Activator-Induced Hemorrhagic Transformation in Experimental Stroke: A Systematic Review and Meta-Analysis
por: Ye, Yang, et al.
Publicado: (2020)

The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator
por: Babenko, Valentina A., et al.
Publicado: (2023)

Rosiglitazone prevents acute pancreatitis through inhibiting microRNA-26a expression
por: Chen, Yan, et al.
Publicado: (2019)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Rosiglitazone promotes glucose metabolism of GIFT tilapia based on the PI3K/Akt signaling pathway
por: Guan, Dong‐Yan, et al.
Publicado: (2021)

Liver Fibrosis Is Associated With Hemorrhagic Transformation in Patients With Acute Ischemic Stroke
por: Yuan, Cheng-Xiang, et al.
Publicado: (2020)

Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease
por: Tomczyk, Marta, et al.
Publicado: (2022)

Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer
por: Langer, Henning Tim, et al.
Publicado: (2023)

Rosiglitazone Ameliorates Spinal Cord Injury via Inhibiting Mitophagy and Inflammation of Neural Stem Cells
por: Meng, Qingqi, et al.
Publicado: (2022)

Rosiglitazone protects against severe hemorrhagic shock-induced organ damage in rats
por: Yang, Fwu-Lin, et al.
Publicado: (2011)

Ziqi Dihuang decoction ameliorates thrombosis in septic rats by inhitbiting plasminogen activator inhibitor-1
por: Geng, YanXia, et al.
Publicado: (2023)

Rosiglitazone ameliorates acute hepatic injury via activating the Nrf2 signaling pathway and inhibiting activation of the NLRP3 inflammasome
por: Ma, Ling, et al.
Publicado: (2022)

Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia
por: Zhang, Wei-Li, et al.
Publicado: (2014)

Rosiglitazone Regulates Anti-Inflammation and Growth Inhibition via PTEN
por: Lin, Chiou-Feng, et al.
Publicado: (2014)

Influence of Rosiglitazone on the Expression of PPARγ, NF-κB, and TNF-α in Rat Model of Ulcerative Colitis
por: Mao, Jing-Wei, et al.
Publicado: (2012)

QiShenYiQi Inhibits Tissue Plasminogen Activator–Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
por: Ye, Yang, et al.
Publicado: (2022)

Co-Crystal of Rosiglitazone With Berberine Ameliorates Hyperglycemia and Insulin Resistance Through the PI3K/AKT/TXNIP Pathway In Vivo and In Vitro
por: He, Qichen, et al.
Publicado: (2022)

Low triiodothyronine syndrome is associated with hemorrhagic transformation in patients with acute ischaemic stroke
por: Huang, Gui-Qian, et al.
Publicado: (2019)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

Predictors of Intracerebral Hemorrhage in Acute Stroke Patients Receiving Intravenous Recombinant Tissue Plasminogen Activator
por: Chenna, Vijay, et al.
Publicado: (2018)

Rosiglitazone ameliorates diffuse axonal injury by reducing loss of tau and up-regulating caveolin-1 expression
por: Zhao, Yong-lin, et al.
Publicado: (2016)

Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance
por: Liu, Dong-Ling, et al.
Publicado: (2021)

Rosiglitazone attenuates the severity of hyperlipidemic severe acute pancreatitis in rats
por: NIYAZ, BATUR, et al.
Publicado: (2013)

Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke
por: Kanazawa, Masato, et al.
Publicado: (2017)

Bellidifolin Inhibits SRY-Related High Mobility Group-Box Gene 9 to Block TGF-β Signalling Activation to Ameliorate Myocardial Fibrosis
por: Yao, Ting-Ting, et al.
Publicado: (2022)

Preparation and in vitro evaluation of enteric-coated tablets of rosiglitazone sodium
por: Pan, Xin-mei, et al.
Publicado: (2015)

Improvement of abnormal liver enzymes after rosiglitazone treatment in Chinese type 2 diabetes
por: Zheng, Jing-Quan, et al.
Publicado: (2012)

Ginkgo biloba extract and its diterpene ginkgolide constituents ameliorate the metabolic disturbances caused by recombinant tissue plasminogen activator in rat prefrontal cortex
por: Chen, Zhi, et al.
Publicado: (2018)

Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage
por: Kunjukunju, Nancy, et al.
Publicado: (2011)

Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice
por: Zhu, Yuan, et al.
Publicado: (2021)

Risk Factors Associated with Outcomes of Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Ischemic Stroke
por: Tseng, Yi-Ju, et al.
Publicado: (2020)

Combination of vildagliptin and rosiglitazone ameliorates nonalcoholic fatty liver disease in C57BL/6 mice
por: Mookkan, Jeyamurugan, et al.
Publicado: (2014)

Rosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits
por: LI, CHEN, et al.
Publicado: (2015)

Protocol for engineering E. coli Nissle 1917 to diagnose, record, and ameliorate inflammatory bowel disease in mice
por: Zou, Zhen-Ping, et al.
Publicado: (2023)

All-trans retinoic acid shifts rosiglitazone-induced adipogenic differentiation to osteogenic differentiation in mouse embryonic fibroblasts
por: Shao, Ying, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1666f79dh67p74765k923fc2fv